Sign In
Buy XLV
$161.41
+0.570 (+0.354%)
At Close: Jul 13, 2026
Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)?
01:45pm, Saturday, 11'th Jul 2026
State Street Health Care Select Sector SPDR ETF offers a lower expense ratio and a higher dividend yield than Invesco Nasdaq Biotechnology ETF Invesco Nasdaq Biotechnology ETF provides concentrated ex
Not Just Tech: Invest in Innovation With Healthcare
04:12pm, Thursday, 09'th Jul 2026
Traditionally speaking, folks that have looked to tap into innovation in the AI space have done so through tech exposure, particularly with mega-cap names. This is not a surprise, considering the inte
Stocks Look Shaky, But This Sector is Booming (Biotech)
02:06pm, Thursday, 09'th Jul 2026
Biotechnology stocks like Illumina, Eli Lilly and Exelixis have quietly turned into the new market leaders.
4 Defensive Stocks to Take Refuge in as Tech Sell-off Continues
09:26am, Wednesday, 08'th Jul 2026
COLL, IRWD, AMTB and DUK stand out as defensive stock picks as investors rotate from AI-driven tech amid the ongoing sell-off and seek safer sectors.
Goldman’s Top Strategist Sees a Dangerous Amount of Leverage Piling Up
02:45pm, Tuesday, 07'th Jul 2026
Ben Snider, Chief U.S. Equity Strategist at Goldman Sachs, went on CNBC to say something that should register with anyone who has been happily riding this market higher. The character of this market i
3 Healthcare ETFs to Own in a Choppy Stock Market
02:04pm, Monday, 06'th Jul 2026
Healthcare stocks are attractive in a choppy market. These funds, focusing on the broader sector, drugmakers, and biotechs, are worth a look.
Weak June Jobs Data Likely to Boost These ETF Areas
12:00pm, Monday, 06'th Jul 2026
Weak June jobs growth boosts hopes of a dovish Fed, putting healthcare, tech, gold and emerging market ETFs in the spotlight.
State Street Health Care ETF Tops Invesco Pharma on Cost and Size
11:45am, Saturday, 04'th Jul 2026
State Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio and far greater assets under management than Invesco Pharmaceuticals ETF. Invesco's ETF focuses exclusively o
Investors Are Rotating Into Healthcare. Here's Why.
03:55pm, Thursday, 02'nd Jul 2026
Janus Henderson portfolio manager Dan Lyons discusses why he sees opportunities for market outperformance in the healthcare sector as innovations in biotechnology, pharmaceuticals and medical devices
SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns
07:45am, Thursday, 02'nd Jul 2026
State Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio of 0.08% compared to 0.44% for iShares Biotechnology ETF. iShares' ETF provides concentrated exposure to 248
Anxious About an AI Bubble? ETFs to Help Navigate the Risk
12:25pm, Tuesday, 30'th Jun 2026
Stretched tech valuations are reviving AI bubble fears. These ETFs can help navigate the uncertainty.
Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It
05:00pm, Monday, 29'th Jun 2026
Big pharma's patent cliff risk is somewhat overstated, as layered IP and litigation often extend exclusivity beyond headline expiries. Incremental innovation—new formulations, improved delivery, and
Biotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs
12:11pm, Monday, 29'th Jun 2026
LLY, ABBV, BIIB and JNJ hit new 52-week highs as biotech rallies, with company-specific pipeline, approvals and deal activity adding momentum.
ETF Ways to Navigate the 2026 Midterm Election Cycle
01:01pm, Monday, 22'nd Jun 2026
Markets may face election-driven turbulence in 2026, but post-midterm rebounds are common.
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?
07:20am, Monday, 22'nd Jun 2026
If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the State Street Health Care Select Sector SPDR ETF ETF (XLV), a passively managed e
